273 related articles for article (PubMed ID: 19048591)
1. [Treatment of IgA nephropathy with chronic renal failure].
Pozzi C
G Ital Nefrol; 2008; 25 Suppl 44():83-7. PubMed ID: 19048591
[TBL] [Abstract][Full Text] [Related]
2. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
4. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
[TBL] [Abstract][Full Text] [Related]
5. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.
Locatelli F; Vecchio LD; Pozzi C
Nat Clin Pract Nephrol; 2006 Jan; 2(1):24-31. PubMed ID: 16932386
[TBL] [Abstract][Full Text] [Related]
6. [Management of IgA nephropathy].
Amoroso L; De Sanctis L; Cappelli P; Di Vito R; Sirolli V; Bonomini M
G Ital Nefrol; 2011; 28(6):622-32. PubMed ID: 22167613
[TBL] [Abstract][Full Text] [Related]
7. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
[TBL] [Abstract][Full Text] [Related]
8. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
Kanno Y; Okada H; Saruta T; Suzuki H
Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.
Manno C; Gesualdo L; D'Altri C; Rossini M; Grandaliano G; Schena FP
J Nephrol; 2001; 14(4):248-52. PubMed ID: 11506246
[TBL] [Abstract][Full Text] [Related]
12. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
Courtney AE; McNamee PT; Nelson WE; Maxwell AP
Nephrol Dial Transplant; 2006 Dec; 21(12):3550-4. PubMed ID: 16968729
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial.
Locatelli F; Pozzi C; Del Vecchio L; Andrulli S; Pani A; Fogazzi G; Altieri P; Ponticelli C
J Nephrol; 1999; 12(5):308-11. PubMed ID: 10630693
[TBL] [Abstract][Full Text] [Related]
14. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
Maixnerova D; Bauerova L; Skibova J; Rysava R; Reiterova J; Merta M; Honsova E; Tesar V
Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776
[TBL] [Abstract][Full Text] [Related]
15. IgA nephropathy in kidney allograft recipients-therapeutic perspective.
Pazik J; Baczkowska T; Lewandowski Z; Lewandowska D; Ostrowska J; Perkowska Ptasińska A; Mróz A; Miszewska-Szyszkowska D; Rowinski W; Durlik M
Transplant Proc; 2006; 38(1):112-4. PubMed ID: 16504678
[TBL] [Abstract][Full Text] [Related]
16. Can immunosuppressive drugs slow the progression of IgA nephropathy?
Goumenos D; Ahuja M; Shortland JR; Brown CB
Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[TBL] [Abstract][Full Text] [Related]
18. Treatment of IgA nephropathy with renal insufficiency.
Pozzi C; Sarcina C; Ferrario F
J Nephrol; 2016 Aug; 29(4):551-8. PubMed ID: 26743078
[TBL] [Abstract][Full Text] [Related]
19. Favorable outcome of renal transplantation in patients with IgA nephropathy.
Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
[TBL] [Abstract][Full Text] [Related]
20. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
